State of New Jersey Common Pension Fund D Buys Shares of 137,942 Oscar Health, Inc. $OSCR

State of New Jersey Common Pension Fund D purchased a new position in Oscar Health, Inc. (NYSE:OSCR) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 137,942 shares of the company’s stock, valued at approximately $2,611,000. State of New Jersey Common Pension Fund D owned approximately 0.05% of Oscar Health at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. Farther Finance Advisors LLC lifted its holdings in shares of Oscar Health by 4,420.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock worth $25,000 after acquiring an additional 1,282 shares during the last quarter. Jones Financial Companies Lllp increased its stake in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the last quarter. Strs Ohio purchased a new stake in Oscar Health during the first quarter valued at about $30,000. Atlantic Union Bankshares Corp purchased a new stake in Oscar Health during the second quarter valued at about $33,000. Finally, Tsfg LLC bought a new stake in Oscar Health during the third quarter worth about $38,000. Institutional investors own 75.70% of the company’s stock.

Insider Activity

In other news, CFO Richard Scott Blackley sold 25,135 shares of the stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $416,989.65. Following the completion of the sale, the chief financial officer directly owned 1,351,034 shares in the company, valued at approximately $22,413,654.06. This represents a 1.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Adam Mcananey sold 1,852 shares of the stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $30,724.68. Following the sale, the insider owned 179,241 shares of the company’s stock, valued at approximately $2,973,608.19. This represents a 1.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 197,125 shares of company stock worth $3,265,300. 24.39% of the stock is currently owned by corporate insiders.

Oscar Health Price Performance

OSCR opened at $13.25 on Friday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.96 and a quick ratio of 0.92. The stock’s 50 day simple moving average is $14.95 and its 200 day simple moving average is $16.70. The firm has a market cap of $3.51 billion, a price-to-earnings ratio of -7.61 and a beta of 1.90. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.80.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative net margin of 3.79% and a negative return on equity of 39.35%. The company had revenue of $2.76 billion for the quarter, compared to analysts’ expectations of $3.12 billion. During the same period last year, the company posted ($0.62) EPS. The business’s revenue for the quarter was up 17.3% compared to the same quarter last year. As a group, analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on OSCR shares. Wells Fargo & Company reduced their price objective on Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research report on Thursday, November 13th. Barclays set a $18.00 target price on Oscar Health and gave the stock an “equal weight” rating in a research note on Monday, January 5th. UBS Group reissued a “neutral” rating and set a $15.00 price target on shares of Oscar Health in a research note on Wednesday, February 11th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a report on Thursday, January 22nd. Finally, Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a research note on Saturday, February 14th. Two research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $16.88.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.